Interestingly, the transcriptomic study conducted by Leandro et al., 2018, showed promising findings that increased expression of the RGS1 gene in the PBMCs of AD patients has potential as a peripheral biomarker [75]. This evidence concerns the gene RGS1 and Alzheimer disease.